论文部分内容阅读
目的:通过比较单用降压药物与联合使用调脂药物对原发性高血压病患者的临床治疗效果,评价降压联合调脂治疗的临床使用价值。方法:选取自2009年5月至2011年7月入住我院进行治疗的原发性高血压病患者80例,对其进行随机分为实验组与对照组各40例,对照组单纯采取降压治疗,实验组在此基础上使用他汀类调脂药物进行治疗,比较分析两组患者的临床治疗效果。结果:采取对照治疗后,实验组的血压达标率显著高于对照组(87.5%>72.5%,P<0.05);两组患者收缩压与舒张压均得到有效下降,但实验组的下降幅度显著优于对照组(P<0.05);而且测量各组患者血脂变化,实验组的改善情况显著。结论:对于原发性高血压病患者的临床治疗,降压联合调脂治疗方法具有更好的临床价值,值得临床推广。
Objective: To evaluate the clinical value of antihypertensive combined with lipid-lowering therapy by comparing the clinical effects of antihypertensive drugs and lipid-lowering drugs alone in patients with essential hypertension. Methods: Eighty patients with essential hypertension admitted to our hospital from May 2009 to July 2011 were randomly divided into experimental group and control group (n = 40), while those in control group Pressure treatment, the experimental group on the basis of the use of statins lipid-lowering drugs for treatment, comparative analysis of two groups of patients with clinical treatment. Results: After taking the control treatment, the blood pressure compliance rate in the experimental group was significantly higher than that in the control group (87.5%> 72.5%, P <0.05). Both systolic and diastolic blood pressure decreased significantly in both groups, but the decline rate in the experimental group was significant Better than the control group (P <0.05); and the change of blood lipid in each group was measured, and the improvement in the experimental group was significant. Conclusion: For the clinical treatment of patients with essential hypertension, the combination of antihypertensive therapy and lipid lowering therapy has better clinical value and is worthy of clinical promotion.